Case details

Print
Merger control
Case reference
CCENT/2005/10 - ANGELINI FARMACÊUTICA, LDA/AVENTIS PHARMA, LDA
Acquiring
Angelini Farmacêutica, Lda
Description
an undertaking, under Portuguese law, belonging to the Angelini group; it produces, markets, promotes, imports, exports and distributes diagnostic tests and pharmaceutical, biological and other products for human and veterinary medicine;
Acquired
Aventis Pharma, Lda
Description
an undertaking, under Portuguese law, belonging to the Aventis group; it produces, imports and distributes technical and metallurgical chemical products, human and veterinary medicines, fertilizers, seeds and other farming products, along with synthetic materials, fibres, foil and products and equipment for reproduction technology;
Sector
  • Extractive and manufacturing Industries
Activity (NACE)
  • C21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
Applicable legislation
Art. 9(1)(a) (Law 18)
Notification thresholds
Market share
Type of merger
Conglomerate
Cooperation with sector regulators
Status
Closed
Type of Investigation
Phase 1
AdC’s decision
Non-opposition
Case description
Notified on 9 February 2005, this merger consists of the acquisition by Angelini Farmacêutica, Lda, (Angelini Farmacêutica), from Aventis Pharma, Lda (Aventis Pharma) and Laboratórios Roussel, Lda, (Laboratórios Roussel), of the rights and obligations relating to the marketing of the product Adalgur N®, in Portugal.
Timeline
Click here to see your activities